New publication from experts examines the #BRIGHTLINE-1 trial and the potential of #brigimadlin for people with dedifferentiated #liposarcoma. Read more: bit.ly/BrigimadlinU... #DDLPS #SarcomaResearch #SaveBrigimadlin #PatientVoices @boehringerglobal.bsky.social